West Pharmaceutical Services (WST) Notes Payables (2018 - 2024)

West Pharmaceutical Services has disclosed Notes Payables across 7 years of filings, most recently posting $132.9 million for Q2 2024.

• In Q2 2024, Notes Payables rose 5940.91% year-over-year to $132.9 million; the TTM figure through Jun 2024 stood at $132.9 million (up 5940.91% YoY), while the FY2023 annual figure was $134.0 million, up 5990.91% from the prior year.
• Notes Payables came in at $132.9 million for Q2 2024 at West Pharmaceutical Services, roughly flat from $133.4 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $134.0 million in Q4 2023 to a low of $2.2 million in Q4 2022.
• Average Notes Payables over 5 years is $54.3 million, with a median of $44.2 million recorded in 2021.
• Year-over-year, Notes Payables plunged 95.02% in 2022 and surged 5990.91% in 2023.
• Over 5 years, Notes Payables stood at $2.3 million in 2020, then soared by 1821.74% to $44.2 million in 2021, then sank by 95.02% to $2.2 million in 2022, then surged by 5990.91% to $134.0 million in 2023, then dropped by 0.82% to $132.9 million in 2024.
• Per Business Quant data, the three most recent Notes Payables figures were $132.9 million in Q2 2024, $133.4 million in Q1 2024, and $134.0 million in Q4 2023.